BioRestorative Therapies Inc (BRTX)

[declaes]

No it does not and it is already explaind on this board. I will copy past it here again. If the pps goes to $1 there will be no stock issued. Here you go:


On Page 21, Section 6.5, Item (a), it states what you are referring to where it says that...

Quote:
http://www.biorestorative.com/wp-content/uploads/2020/07/DISCLOSURE-STATEMENT-OF-REORGANIZATION.pdf
In accordance with section 1145(a)(1) of the Bankruptcy Code and subject to the Leak Out Restriction, shares of Common Stock in the Reorganized Debtor in an amount equal to the Allowed amount of the General Unsecured Claim multiplied by one-hundred (100); or


Unsecured Claim = $13,797,835
Multiple to common stock = 100

So...

$13,797,835 x 100 = 1,379,783,500 Potential Additional Shares

Then notice that one important word if you keep reading after that part that you are referring. That important word is... or ...at the end of that paragraph. This is the reason why I say "potential" additional shares because following that word... or ... that's listed under Page 21, Section 6.5, Item (b) is where it says a lot that leaves a lot of room for flexibility to deviate considering that there is an anti-dilution provision in place. This allows the stock to appreciate to provide the flexibility for positive deviations for a resolution to take place.

It first stated within that following paragraph that... Provided that the holder of the Allowed General Unsecured Claim provides Cash to the Reorganized Debtor on or before the Effective Date equal to not less than the Financing Amount, and subject to Section 5.2 of the Plan:...

Then this is where it starts to get very interesting for the better to say the least where it then says... (1) in accordance with section 1145(a)(1) of the Bankruptcy Code, in exchange for its Allowed General Unsecured Claim, and subject to the Leak Out Restriction, a Convertible Plan Note equal to the amount of the Allowed General Unsecured Claim; (2) a Secured Convertible Plan Note equal to the Financing Amount; and (3) one (1) Plan Warrant for each dollar of Financing Amount.

Consider this as an example: This means that if the price goes up to .30 per share, a Convertible Note to remedy the $13,797,835 can be issued which would only dilute BRTXQ to the tune of an extra 45,992,783 shares. The higher the share price goes, the less shares needed to resolve the matter and the contrary. Keep in mind too, Auctus is a friendly as they are friend and not foe. They know just how huge this can be since BRTXQ have FDA Phase II Approval for Clinical Trials for their drug BRTX-100